BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 28412318)

  • 1. Nontraditional Lipid Variables Predict Recurrent Brain Ischemia in Embolic Stroke of Undetermined Source.
    de la Riva P; Zubikarai M; Sarasqueta C; Tainta M; Muñoz-Lopetegui A; Andrés-Marín N; González F; Díez N; de Arce A; Bergareche A; Lopez de Munain A; Martínez-Zabaleta M
    J Stroke Cerebrovasc Dis; 2017 Aug; 26(8):1670-1677. PubMed ID: 28412318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of Recurrent Ischemic Stroke in Patients with Embolic Strokes of Undetermined Source and Effects of Rivaroxaban Versus Aspirin According to Risk Status: The NAVIGATE ESUS Trial.
    Hart RG; Veltkamp RC; Sheridan P; Sharma M; Kasner SE; Bangdiwala SI; Ntaios G; Shoamanesh A; Ameriso SF; Toni D; Czlonkowska A; Lindgren A; Hankey GJ; Perera KS; Shuaib A; Coutts SB; Gagliardi RJ; Berkowitz SD; Mundl H; Peters G; Connolly SJ;
    J Stroke Cerebrovasc Dis; 2019 Aug; 28(8):2273-2279. PubMed ID: 31160218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Embolic strokes of undetermined source in young adults: baseline characteristics and long-term outcome.
    Martinez-Majander N; Aarnio K; Pirinen J; Lumikari T; Nieminen T; Lehto M; Sinisalo J; Kaste M; Tatlisumak T; Putaala J
    Eur J Neurol; 2018 Mar; 25(3):535-541. PubMed ID: 29218790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Functional Outcome and Stroke Recurrence in Patients with Embolic Stroke of Undetermined Source (ESUS) vs. Cardioembolic Stroke Patients.
    Arauz A; Morelos E; Colín J; Roldán J; Barboza MA
    PLoS One; 2016; 11(11):e0166091. PubMed ID: 27832136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Embolic strokes of undetermined source in the Athens stroke registry: a descriptive analysis.
    Ntaios G; Papavasileiou V; Milionis H; Makaritsis K; Manios E; Spengos K; Michel P; Vemmos K
    Stroke; 2015 Jan; 46(1):176-81. PubMed ID: 25378429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Embolic Stroke of Undetermined Source and Detection of Atrial Fibrillation on Follow-Up: How Much Causality Is There?
    Ntaios G; Papavasileiou V; Lip GY; Milionis H; Makaritsis K; Vemmou A; Koroboki E; Manios E; Spengos K; Michel P; Vemmos K
    J Stroke Cerebrovasc Dis; 2016 Dec; 25(12):2975-2980. PubMed ID: 27612625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk Stratification for Recurrence and Mortality in Embolic Stroke of Undetermined Source.
    Ntaios G; Vemmos K; Lip GY; Koroboki E; Manios E; Vemmou A; Rodríguez-Campello A; Cuadrado-Godia E; Giralt-Steinhauer E; Arnao V; Caso V; Paciaroni M; Diez-Tejedor E; Fuentes B; Pérez Lucas J; Arauz A; Ameriso SF; Hawkes MA; Pertierra L; Gómez-Schneider M; Bandini F; Chavarria Cano B; Iglesias Mohedano AM; García Pastor A; Gil-Núñez A; Putaala J; Tatlisumak T; Barboza MA; Athanasakis G; Makaritsis K; Papavasileiou V
    Stroke; 2016 Sep; 47(9):2278-85. PubMed ID: 27507859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Embolic strokes of undetermined source in a cohort of Polish stroke patients.
    Bembenek JP; Karlinski MA; Kurkowska-Jastrzebska I; Czlonkowska A
    Neurol Sci; 2018 Jun; 39(6):1041-1047. PubMed ID: 29556872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age- and sex-specific analysis of patients with embolic stroke of undetermined source.
    Ntaios G; Lip GYH; Vemmos K; Koroboki E; Manios E; Vemmou A; Rodríguez-Campello A; Cuadrado-Godia E; Roquer J; Arnao V; Caso V; Paciaroni M; Diez-Tejedor E; Fuentes B; Pérez Lucas J; Arauz A; Ameriso SF; Pertierra L; Gómez-Schneider M; Hawkes MA; Bandini F; Chavarria Cano B; Iglesias Mohedano AM; García Pastor A; Gil-Núñez A; Putaala J; Tatlisumak T; Barboza MA; Athanasakis G; Gioulekas F; Makaritsis K; Papavasileiou V
    Neurology; 2017 Aug; 89(6):532-539. PubMed ID: 28687720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoprotein(a), other lipoproteins and hemostatic profiles in patients with ischemic stroke: the relation to cardiogenic embolism.
    Dahl T; Kontny F; Slagsvold CE; Christophersen B; Abildgaard U; Odegaard OR; Morkrid L; Dale J
    Cerebrovasc Dis; 2000; 10(2):110-7. PubMed ID: 10686449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relative strength of C-reactive protein and lipid levels as determinants of ischemic stroke compared with coronary heart disease in women.
    Everett BM; Kurth T; Buring JE; Ridker PM
    J Am Coll Cardiol; 2006 Dec; 48(11):2235-42. PubMed ID: 17161253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Septal total atrial conduction time for prediction of atrial fibrillation in embolic stroke of unknown source: a pilot study.
    Sieweke JT; Biber S; Weissenborn K; Heuschmann PU; Akin M; Zauner F; Gabriel MM; Schuppner R; Berliner D; Bauersachs J; Grosse GM; Bavendiek U
    Clin Res Cardiol; 2020 Feb; 109(2):205-214. PubMed ID: 31236691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic Resonance Imaging White Matter Hyperintensity as a Predictor of Stroke Recurrence in Patients with Embolic Stroke of Undetermined Source.
    Kashima S; Shimizu T; Akiyama H; Hasegawa Y
    J Stroke Cerebrovasc Dis; 2018 Dec; 27(12):3613-3620. PubMed ID: 30249517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid levels and the risk of ischemic stroke in women.
    Kurth T; Everett BM; Buring JE; Kase CS; Ridker PM; Gaziano JM
    Neurology; 2007 Feb; 68(8):556-62. PubMed ID: 17310025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low levels of high-density lipoprotein cholesterol in patients with atherosclerotic stroke: a prospective cohort study.
    Yeh PS; Yang CM; Lin SH; Wang WM; Chen PS; Chao TH; Lin HJ; Lin KC; Chang CY; Cheng TJ; Li YH
    Atherosclerosis; 2013 Jun; 228(2):472-7. PubMed ID: 23618097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left Atrial Dilation and Risk of One-Year Readmission after Embolic Stroke of Undetermined Source.
    Jagadeesan V; Culver A; Raiker N; Halverson Q; Prasada S; Chen L; Welty LJ; Prabhakaran S; Maganti K
    J Stroke Cerebrovasc Dis; 2020 Aug; 29(8):104975. PubMed ID: 32689607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-related burden and characteristics of embolic stroke of undetermined source in the real world clinical practice.
    Grifoni E; Giglio D; Guazzini G; Cosentino E; Latini E; Dei A; Del Rosso A; Guarnaccia V; Baldini M; Bartolozzi ML; Martinucci P; Sani F; Giordano A; Dainelli F; Maggi F; Giulietti C; Romagnoli M; Cinotti S; Schipani E; Murgida GS; Di Martino S; Cozzi A; Carli Ballola A; Dacomo D; Valori D; Masotti L
    J Thromb Thrombolysis; 2020 Jan; 49(1):75-85. PubMed ID: 31494844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential characteristics, stroke recurrence, and predictors of covert atrial fibrillation of embolic strokes of undetermined source.
    Hawkes MA; Farez MF; Pertierra L; Gomez-Schneider MM; Pastor-Rueda JM; Ameriso SF
    Int J Stroke; 2018 Feb; 13(2):190-194. PubMed ID: 28756759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ASCOD Phenotyping of Embolic Strokes of Undetermined Source.
    Shimizu T; Kashima S; Akiyama H; Isahaya K; Hasegawa Y
    J Stroke Cerebrovasc Dis; 2020 Feb; 29(2):104491. PubMed ID: 31761736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired Endothelial Function in Embolic Stroke of Undetermined Source.
    Shirai Y; Toi S; Adachi U; Kitagawa K
    J Stroke Cerebrovasc Dis; 2020 Jan; 29(1):104489. PubMed ID: 31706752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.